

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 8.48756223 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.27682981 |
| 3 | protein activation cascade (GO:0072376) | 6.14442516 |
| 4 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.64223707 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.28867104 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 5.24171390 |
| 7 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.21962226 |
| 8 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.21962226 |
| 9 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.21962226 |
| 10 | humoral immune response (GO:0006959) | 5.18048006 |
| 11 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.17644443 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05200575 |
| 13 | B cell proliferation (GO:0042100) | 5.04815636 |
| 14 | positive regulation of respiratory burst (GO:0060267) | 5.02708345 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.95060148 |
| 16 | glomerular filtration (GO:0003094) | 4.76685889 |
| 17 | regulation of antigen processing and presentation (GO:0002577) | 4.70158433 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69289562 |
| 19 | positive regulation of antigen processing and presentation (GO:0002579) | 4.65751840 |
| 20 | detection of bacterium (GO:0016045) | 4.61979584 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.59992635 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 4.46225601 |
| 23 | detection of other organism (GO:0098543) | 4.39730753 |
| 24 | renal filtration (GO:0097205) | 4.27679122 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.13370485 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.01900351 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.96209199 |
| 28 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.92629085 |
| 29 | regulation of respiratory burst (GO:0060263) | 3.88785489 |
| 30 | B cell mediated immunity (GO:0019724) | 3.81793488 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.73204619 |
| 32 | regulation of germinal center formation (GO:0002634) | 3.72323359 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69177138 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68335440 |
| 35 | germinal center formation (GO:0002467) | 3.66673358 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.65483796 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.65483796 |
| 38 | response to type I interferon (GO:0034340) | 3.65347264 |
| 39 | regulation of necroptotic process (GO:0060544) | 3.54015224 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.48116161 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.46673326 |
| 42 | lymph node development (GO:0048535) | 3.46569061 |
| 43 | regulation of B cell differentiation (GO:0045577) | 3.43468003 |
| 44 | mature B cell differentiation (GO:0002335) | 3.32119048 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30111114 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30111114 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.30111114 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30111114 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.30111114 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30111114 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30014403 |
| 52 | negative regulation of cell killing (GO:0031342) | 3.30014403 |
| 53 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.28522254 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24735494 |
| 55 | negative regulation of necroptotic process (GO:0060546) | 3.18261526 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.17979155 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12473959 |
| 58 | positive T cell selection (GO:0043368) | 3.11623414 |
| 59 | immune response-activating signal transduction (GO:0002757) | 3.11467219 |
| 60 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11416163 |
| 61 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.03528242 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 3.02593349 |
| 63 | regulation of protein glycosylation (GO:0060049) | 3.02191620 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 3.00207283 |
| 65 | respiratory burst (GO:0045730) | 2.99862607 |
| 66 | activation of immune response (GO:0002253) | 2.99337227 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.98873030 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96657815 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.93003424 |
| 70 | regulation of B cell proliferation (GO:0030888) | 2.92911118 |
| 71 | negative regulation of humoral immune response (GO:0002921) | 2.92708436 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91862527 |
| 73 | lymphocyte proliferation (GO:0046651) | 2.90904460 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.90860332 |
| 75 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88263009 |
| 76 | negative regulation of bone resorption (GO:0045779) | 2.87816241 |
| 77 | mononuclear cell proliferation (GO:0032943) | 2.87248199 |
| 78 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84015103 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84015103 |
| 80 | antibacterial humoral response (GO:0019731) | 2.81902023 |
| 81 | T cell selection (GO:0045058) | 2.78340618 |
| 82 | antimicrobial humoral response (GO:0019730) | 2.76548288 |
| 83 | regulation of type 2 immune response (GO:0002828) | 2.76288456 |
| 84 | positive regulation of Rap GTPase activity (GO:0032854) | 2.75295063 |
| 85 | retina homeostasis (GO:0001895) | 2.70970770 |
| 86 | cellular response to interferon-gamma (GO:0071346) | 2.70603332 |
| 87 | B cell activation (GO:0042113) | 2.70412383 |
| 88 | positive regulation of B cell activation (GO:0050871) | 2.69665746 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.68525008 |
| 90 | leukocyte proliferation (GO:0070661) | 2.68336690 |
| 91 | negative T cell selection (GO:0043383) | 2.68084450 |
| 92 | positive regulation of T cell migration (GO:2000406) | 2.67682215 |
| 93 | regulation of necrotic cell death (GO:0010939) | 2.67418395 |
| 94 | response to interferon-beta (GO:0035456) | 2.67208440 |
| 95 | B cell homeostasis (GO:0001782) | 2.67163918 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.66883518 |
| 97 | lymphocyte homeostasis (GO:0002260) | 2.64739049 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 2.64156453 |
| 99 | positive regulation of B cell proliferation (GO:0030890) | 2.63538602 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.8401221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.74973588 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.40139345 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08761611 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99284491 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.83913857 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.19903701 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91599011 |
| 8 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.86689559 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84674523 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.57547012 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.55862792 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49514814 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45987495 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45701872 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42528484 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33749798 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28369895 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.27696292 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06072769 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02543491 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01325276 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90972945 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80342225 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78048929 |
| 25 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.64244444 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61748364 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60486390 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58145001 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.56850301 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54539917 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54452843 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54111239 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53998149 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.53979263 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53883074 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51647758 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47640449 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43752675 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42050050 |
| 40 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40821630 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38221436 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35150172 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32845799 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27251497 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26934718 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23144013 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19976554 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16830196 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16462784 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14535451 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14501395 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11799815 |
| 53 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10782676 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10415551 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09658977 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07569586 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06920090 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06811224 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06575486 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06533374 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03055860 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02236838 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01629857 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00859104 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 0.98795490 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98101892 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97456227 |
| 68 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96161310 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95776889 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 0.94532821 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93574022 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91425828 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89166283 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87921770 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86978971 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.86831375 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85981697 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84476388 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84037454 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82663678 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81070343 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80415876 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80276724 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80024766 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79278300 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77413520 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76198884 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75670760 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75520590 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73793836 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73317097 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72308696 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72107940 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.68907487 |
| 95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68654550 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64211793 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61853533 |
| 98 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.61318643 |
| 99 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.60262092 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58967138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.71419480 |
| 2 | MP0005387_immune_system_phenotype | 4.11616672 |
| 3 | MP0001790_abnormal_immune_system | 4.11616672 |
| 4 | MP0001800_abnormal_humoral_immune | 3.81622525 |
| 5 | MP0003724_increased_susceptibility_to | 3.51989636 |
| 6 | MP0000685_abnormal_immune_system | 3.38483592 |
| 7 | MP0003303_peritoneal_inflammation | 3.03405615 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.00919958 |
| 9 | MP0005671_abnormal_response_to | 2.90837945 |
| 10 | MP0009785_altered_susceptibility_to | 2.88806927 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.83474591 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.83460792 |
| 13 | MP0009278_abnormal_bone_marrow | 2.78962853 |
| 14 | MP0002723_abnormal_immune_serum | 2.77413124 |
| 15 | MP0003436_decreased_susceptibility_to | 2.73687933 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.69007943 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.67575486 |
| 18 | MP0001819_abnormal_immune_cell | 2.66088999 |
| 19 | MP0005025_abnormal_response_to | 2.63420101 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.32638110 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.24395741 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.21169640 |
| 23 | MP0002398_abnormal_bone_marrow | 2.17370409 |
| 24 | MP0002419_abnormal_innate_immunity | 2.14764497 |
| 25 | MP0000716_abnormal_immune_system | 2.13085143 |
| 26 | MP0002132_abnormal_respiratory_system | 1.97069260 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.91046553 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.79107431 |
| 29 | MP0002429_abnormal_blood_cell | 1.67976363 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.66105661 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.65330329 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.65330329 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.64021748 |
| 34 | MP0004947_skin_inflammation | 1.62019509 |
| 35 | MP0002405_respiratory_system_inflammati | 1.59272401 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.57034287 |
| 37 | MP0002722_abnormal_immune_system | 1.52932205 |
| 38 | MP0002006_tumorigenesis | 1.51596501 |
| 39 | MP0002933_joint_inflammation | 1.51357726 |
| 40 | MP0005275_abnormal_skin_tensile | 1.48711584 |
| 41 | MP0005310_abnormal_salivary_gland | 1.47075683 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.40316998 |
| 43 | MP0005166_decreased_susceptibility_to | 1.39327107 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.36271000 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.33954471 |
| 46 | MP0003045_fibrosis | 1.33434420 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.23471081 |
| 48 | MP0005451_abnormal_body_composition | 1.22203671 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.21426645 |
| 50 | MP0001873_stomach_inflammation | 1.16349419 |
| 51 | MP0001849_ear_inflammation | 1.12963626 |
| 52 | MP0008469_abnormal_protein_level | 1.12150316 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.11033645 |
| 54 | MP0003866_abnormal_defecation | 1.09176823 |
| 55 | MP0001663_abnormal_digestive_system | 1.08950448 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.08543904 |
| 57 | MP0003448_altered_tumor_morphology | 1.06994916 |
| 58 | MP0005164_abnormal_response_to | 1.02320558 |
| 59 | MP0000249_abnormal_blood_vessel | 1.00613992 |
| 60 | MP0006082_CNS_inflammation | 1.00487454 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.00390449 |
| 62 | MP0002396_abnormal_hematopoietic_system | 0.99080823 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 0.97670221 |
| 64 | MP0003279_aneurysm | 0.96539066 |
| 65 | MP0003075_altered_response_to | 0.96354852 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.93747932 |
| 67 | MP0005023_abnormal_wound_healing | 0.92356120 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 0.92278279 |
| 69 | MP0009764_decreased_sensitivity_to | 0.91886328 |
| 70 | MP0001851_eye_inflammation | 0.86997547 |
| 71 | MP0005390_skeleton_phenotype | 0.86124578 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.85897897 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.83826753 |
| 74 | MP0004272_abnormal_basement_membrane | 0.83363661 |
| 75 | MP0000858_altered_metastatic_potential | 0.83044536 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.80058652 |
| 77 | MP0000490_abnormal_crypts_of | 0.79125077 |
| 78 | MP0004883_abnormal_blood_vessel | 0.76368980 |
| 79 | MP0003252_abnormal_bile_duct | 0.74444252 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.72869650 |
| 81 | MP0008004_abnormal_stomach_pH | 0.72447612 |
| 82 | MP0001542_abnormal_bone_strength | 0.70122150 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.68348624 |
| 84 | MP0001958_emphysema | 0.68202283 |
| 85 | MP0000462_abnormal_digestive_system | 0.67984156 |
| 86 | MP0005388_respiratory_system_phenotype | 0.65453559 |
| 87 | MP0002133_abnormal_respiratory_system | 0.65453559 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.64485698 |
| 89 | MP0000343_altered_response_to | 0.64476753 |
| 90 | MP0003828_pulmonary_edema | 0.63967448 |
| 91 | MP0008874_decreased_physiological_sensi | 0.62686579 |
| 92 | MP0003795_abnormal_bone_structure | 0.62550796 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58755557 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.58180725 |
| 95 | MP0000613_abnormal_salivary_gland | 0.58180482 |
| 96 | MP0000383_abnormal_hair_follicle | 0.56242496 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.55952778 |
| 98 | MP0001191_abnormal_skin_condition | 0.55165689 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.53954116 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.52828921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.97760931 |
| 2 | B lymphocytopenia (HP:0010976) | 6.60198940 |
| 3 | Abnormality of B cell number (HP:0010975) | 6.57310678 |
| 4 | Gastrointestinal stroma tumor (HP:0100723) | 6.04517887 |
| 5 | Prostate neoplasm (HP:0100787) | 5.52516814 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 5.36789949 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.24871881 |
| 8 | Meningitis (HP:0001287) | 5.00967847 |
| 9 | Cellulitis (HP:0100658) | 4.98319644 |
| 10 | Thyroiditis (HP:0100646) | 4.85243573 |
| 11 | Vasculitis (HP:0002633) | 4.83954335 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 4.46210133 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.36671378 |
| 14 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.21599658 |
| 15 | Abnormality of the prostate (HP:0008775) | 4.13471901 |
| 16 | Hypoplasia of the thymus (HP:0000778) | 4.06933375 |
| 17 | Recurrent viral infections (HP:0004429) | 4.03251068 |
| 18 | Eczematoid dermatitis (HP:0000976) | 4.01026401 |
| 19 | Recurrent pneumonia (HP:0006532) | 3.95704712 |
| 20 | Verrucae (HP:0200043) | 3.95331097 |
| 21 | Papilloma (HP:0012740) | 3.95331097 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.86413201 |
| 23 | Osteomyelitis (HP:0002754) | 3.86144953 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.74242223 |
| 25 | Leukocytosis (HP:0001974) | 3.68198500 |
| 26 | T lymphocytopenia (HP:0005403) | 3.67834442 |
| 27 | Eosinophilia (HP:0001880) | 3.67610658 |
| 28 | Chronic sinusitis (HP:0011109) | 3.63077378 |
| 29 | Granulocytopenia (HP:0001913) | 3.59629864 |
| 30 | Combined immunodeficiency (HP:0005387) | 3.57341540 |
| 31 | Sepsis (HP:0100806) | 3.55114648 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.50667190 |
| 33 | Lymphopenia (HP:0001888) | 3.40888248 |
| 34 | Recurrent sinusitis (HP:0011108) | 3.33733271 |
| 35 | Emphysema (HP:0002097) | 3.31727850 |
| 36 | Skin rash (HP:0000988) | 3.28412212 |
| 37 | Colitis (HP:0002583) | 3.23825579 |
| 38 | Recurrent lower respiratory tract infections (HP:0002783) | 3.18778896 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18367108 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.16788650 |
| 41 | Restrictive lung disease (HP:0002091) | 3.15761644 |
| 42 | Inflammation of the large intestine (HP:0002037) | 3.14590753 |
| 43 | Bronchitis (HP:0012387) | 3.08635487 |
| 44 | IgG deficiency (HP:0004315) | 3.00948869 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.98772306 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.96827238 |
| 47 | Hypoproteinemia (HP:0003075) | 2.93296046 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90414622 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.89966640 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.87644685 |
| 51 | Myositis (HP:0100614) | 2.84101449 |
| 52 | Abnormality of T cells (HP:0002843) | 2.71998364 |
| 53 | Recurrent otitis media (HP:0000403) | 2.69793593 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65262441 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64587626 |
| 56 | Obstructive lung disease (HP:0006536) | 2.64587626 |
| 57 | Increased IgE level (HP:0003212) | 2.61732897 |
| 58 | Orchitis (HP:0100796) | 2.60172088 |
| 59 | Calf muscle hypertrophy (HP:0008981) | 2.56406846 |
| 60 | Lymphoma (HP:0002665) | 2.51417017 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.46400553 |
| 62 | Optic neuritis (HP:0100653) | 2.46400553 |
| 63 | Urticaria (HP:0001025) | 2.44030529 |
| 64 | Metaphyseal dysplasia (HP:0100255) | 2.43990588 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.36954104 |
| 66 | Abnormality of male internal genitalia (HP:0000022) | 2.33270364 |
| 67 | Glomerulonephritis (HP:0000099) | 2.31934937 |
| 68 | Abnormality of complement system (HP:0005339) | 2.31858307 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.30720087 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.27650839 |
| 71 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.22809939 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.22793403 |
| 73 | Skin ulcer (HP:0200042) | 2.20613435 |
| 74 | Hemoptysis (HP:0002105) | 2.20231693 |
| 75 | Gingivitis (HP:0000230) | 2.18485127 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17588965 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17588965 |
| 78 | Complement deficiency (HP:0004431) | 2.09518360 |
| 79 | Metaphyseal cupping (HP:0003021) | 2.08522252 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.05012125 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.04052521 |
| 82 | Recurrent skin infections (HP:0001581) | 2.03834883 |
| 83 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.02746726 |
| 84 | Nephritis (HP:0000123) | 2.01126330 |
| 85 | Premature loss of primary teeth (HP:0006323) | 1.99850755 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.97336664 |
| 87 | Encephalitis (HP:0002383) | 1.96410113 |
| 88 | Stomatitis (HP:0010280) | 1.93657034 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 1.92920908 |
| 90 | Type II lissencephaly (HP:0007260) | 1.90721397 |
| 91 | Dehydration (HP:0001944) | 1.90515874 |
| 92 | Abnormality of the pleura (HP:0002103) | 1.87748914 |
| 93 | Xerostomia (HP:0000217) | 1.84901537 |
| 94 | Hematochezia (HP:0002573) | 1.77289730 |
| 95 | Keratoconjunctivitis (HP:0001096) | 1.75239249 |
| 96 | Neoplasm of the lung (HP:0100526) | 1.74840984 |
| 97 | Cupped ribs (HP:0000887) | 1.73666674 |
| 98 | Arthralgia (HP:0002829) | 1.72625022 |
| 99 | Leukopenia (HP:0001882) | 1.72526626 |
| 100 | Spondylolisthesis (HP:0003302) | 1.71641814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.83897922 |
| 2 | BLK | 3.64366047 |
| 3 | CDK19 | 3.63470740 |
| 4 | MAP4K1 | 3.21820177 |
| 5 | RIPK4 | 3.02297853 |
| 6 | TYK2 | 3.01500366 |
| 7 | KIT | 2.86879994 |
| 8 | GRK6 | 2.69563076 |
| 9 | MAP3K13 | 2.62421910 |
| 10 | SYK | 2.46899043 |
| 11 | IRAK4 | 2.26311931 |
| 12 | FES | 2.15798498 |
| 13 | BMPR2 | 2.14079328 |
| 14 | BTK | 1.88798787 |
| 15 | LYN | 1.85128140 |
| 16 | IKBKE | 1.83471281 |
| 17 | JAK3 | 1.67753136 |
| 18 | JAK1 | 1.64444811 |
| 19 | TAOK3 | 1.46527263 |
| 20 | ZAP70 | 1.45513902 |
| 21 | PRPF4B | 1.44498801 |
| 22 | CSF1R | 1.43642747 |
| 23 | CDC42BPA | 1.43345866 |
| 24 | TEC | 1.40869050 |
| 25 | TBK1 | 1.38033010 |
| 26 | TGFBR2 | 1.35218984 |
| 27 | MAP3K14 | 1.31673584 |
| 28 | SIK3 | 1.31631482 |
| 29 | ARAF | 1.25595045 |
| 30 | MATK | 1.21453007 |
| 31 | KDR | 1.19611021 |
| 32 | CSK | 1.19237904 |
| 33 | RIPK1 | 1.16542556 |
| 34 | LCK | 1.15169855 |
| 35 | ITK | 1.15001149 |
| 36 | IKBKB | 1.13801466 |
| 37 | HCK | 1.13058486 |
| 38 | FGFR4 | 1.10592821 |
| 39 | TXK | 1.07605317 |
| 40 | MAP3K3 | 1.03080829 |
| 41 | MAPK11 | 1.02934908 |
| 42 | MAP3K1 | 0.96297795 |
| 43 | TGFBR1 | 0.95491506 |
| 44 | MAP3K10 | 0.91415407 |
| 45 | PRKD2 | 0.88323819 |
| 46 | JAK2 | 0.86722627 |
| 47 | MAP2K3 | 0.79858400 |
| 48 | MAPK12 | 0.77673718 |
| 49 | EPHB1 | 0.75918741 |
| 50 | FYN | 0.73806061 |
| 51 | PKN2 | 0.68424704 |
| 52 | ADRBK2 | 0.66245374 |
| 53 | TAOK1 | 0.65676951 |
| 54 | CDK12 | 0.64275030 |
| 55 | FLT3 | 0.63729711 |
| 56 | FGFR3 | 0.62592060 |
| 57 | PIK3CG | 0.60397000 |
| 58 | EPHA3 | 0.59897956 |
| 59 | NLK | 0.58842711 |
| 60 | MAP3K7 | 0.58409238 |
| 61 | MAPKAPK2 | 0.57633752 |
| 62 | PDK1 | 0.57577317 |
| 63 | RPS6KB1 | 0.54479536 |
| 64 | MAPK7 | 0.54306254 |
| 65 | MET | 0.53336951 |
| 66 | PRKCQ | 0.53089637 |
| 67 | FER | 0.51393724 |
| 68 | PIM1 | 0.50430191 |
| 69 | GRK5 | 0.46832956 |
| 70 | MYLK | 0.46628688 |
| 71 | MST1R | 0.46473147 |
| 72 | PRKD1 | 0.46388615 |
| 73 | MAP3K11 | 0.45333352 |
| 74 | EIF2AK3 | 0.44315653 |
| 75 | GRK7 | 0.43974421 |
| 76 | TESK2 | 0.43654109 |
| 77 | CHUK | 0.42758249 |
| 78 | LRRK2 | 0.42748596 |
| 79 | PDPK1 | 0.42176427 |
| 80 | ABL1 | 0.40402080 |
| 81 | MAPK4 | 0.39667949 |
| 82 | CLK1 | 0.39431925 |
| 83 | MAPK3 | 0.39132244 |
| 84 | ADRBK1 | 0.38930688 |
| 85 | MAP3K2 | 0.37790031 |
| 86 | MARK3 | 0.35832693 |
| 87 | TAOK2 | 0.35803649 |
| 88 | MAP2K6 | 0.34677549 |
| 89 | STK10 | 0.32579187 |
| 90 | PTK6 | 0.32299016 |
| 91 | MARK2 | 0.31956800 |
| 92 | MAP3K12 | 0.31536164 |
| 93 | INSR | 0.30571873 |
| 94 | TNK2 | 0.30198418 |
| 95 | LATS1 | 0.29366676 |
| 96 | IGF1R | 0.29252291 |
| 97 | PRKCD | 0.29220014 |
| 98 | IRAK1 | 0.29215412 |
| 99 | TRIB3 | 0.28431518 |
| 100 | HIPK2 | 0.27899897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.47685742 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.23195567 |
| 3 | Asthma_Homo sapiens_hsa05310 | 4.02146578 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.79601294 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.69369125 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.69195401 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54459213 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.93832290 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.81375232 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73365557 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.56120145 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.55458793 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49566232 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.16054602 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95902680 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67888413 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66661872 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66338045 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57574987 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.50637516 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.43534593 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.37534123 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36699204 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.29563465 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.28366095 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21798317 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.21280777 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14298034 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11239062 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.09598358 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.06395688 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02164153 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01056979 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97474826 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96251546 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94726226 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93111008 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92366791 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90272795 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88940877 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88115566 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83278237 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82111794 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80308354 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.77595798 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75941971 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75009482 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73425988 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70388379 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70346876 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.67305788 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.61472526 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.60414951 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59637895 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57422431 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.56116900 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55660768 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51690199 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49641170 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45535232 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44235452 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43779635 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43210543 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40638810 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.40044475 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.38751078 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.38279835 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36996898 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34709054 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33196662 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31449944 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30475995 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29279197 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.27867565 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.27379710 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24567334 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23888076 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23359879 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22252657 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19787955 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19701199 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.19699377 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18446339 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16357975 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14819050 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.14590776 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13351186 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13135831 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12715573 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.12003055 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11104117 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.09263634 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.09100419 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08596663 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07498795 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06387457 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06244569 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06145597 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.05795025 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.05394345 |

